Kelly F. Paton

Wellington, WGN 6012, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.

Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.

Journal: Molecules (Basel, Switzerland)

Published: December 17, 2024

Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.

Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice.

Journal: Brain sciences

Published: October 31, 2022

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice.

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice.

Journal: Frontiers in pharmacology

Published: November 11, 2021

The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis.

The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis.

Journal: Frontiers in neurology

Published: September 24, 2021

The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Journal: Neuropharmacology

Published: August 10, 2020

Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Journal: The Journal of pharmacology and experimental therapeutics

Published: May 28, 2020

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain.

Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain.

Journal: Frontiers in neuroscience

Published: March 29, 2020

N-docosahexaenoyl ethanolamine (synaptamide) has antinociceptive effects in male mice.

N-docosahexaenoyl ethanolamine (synaptamide) has antinociceptive effects in male mice.

Journal: European journal of pain (London, England)

Published: August 01, 2019

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Journal: Molecules (Basel, Switzerland)

Published: September 16, 2018

Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.

Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability.

Journal: Journal of medicinal chemistry

Published: April 05, 2017

Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.

Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability.

Journal: Journal of medicinal chemistry

Published: December 14, 2016

The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.

The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.

Journal: European journal of pain (London, England)

Published: December 04, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026